We have two patents that cover a large swarth of technologies centered on detecting human diagnostics. Patent # 8,659,435 B2 and Patent # 10,959,651 B1. 

We are in the business of human diagnostics centered on the translation and understanding of human biomarkers. 

• Application Number: 63/939,509
   
• Status: Patent Pending (Provisional Application)
   
• Filed: 2025
   
• Technology
   
  • non-invasive detection of HIV biomarkers
     
  • detection of cancer-related biomarkers
     
  • AI-assisted spectral analysis
     

• Application Number: 63/823,795
   
• Filed: June 14, 2025
   
• Status: Patent Pending
   

Technology

• AI-driven spectral identification system
   
• CNN neural network models for detecting biomarker signatures
   
• multi-disease detection through spectral data
   

This strengthens the AI layer of our diagnostic platform.

Better Life Technologies Group's mission is to operate a scalable diagnostic ecosystem that can support applications in healthcare screening, public health monitoring, security detection, and food safety analysis. Together, these innovations position Better Life Technologies as a developer of next-generation diagnostic and curative platforms that combine biosensing, artificial intelligence, and connected monitoring systems to enable rapid, non-invasive detection of disease and biological threats. 

 Building on these core sensing technologies, Better Life has expanded into AI-driven spectral analysis and wearable diagnostic platforms, including the HandScan™ system, designed to identify biomarkers associated with diseases such as HIV, cancer, and other pathogens through advanced spectral detection methods and convolutional neural network analysis.  Importantly, we are in the process of integrating new technologies aimed at initial diagnostics and methods of cure.